Celcuity Stock Quote CELC - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

12.46

Bid

11.77

Ask

14.87

Volume

1,207,069

11.62 Day's Range 12.585

11.51 52 Week Range 22.188

Market Cap

462.634M

Previous Close

12.00

Open

11.85

Last Trade

5031

12.4595

(formt)

Last Trade Time

Financial Volume

$ 14,736,509

VWAP

12.2085

Average Volume (3m)

229,745

Shares Outstanding

37,129,556

Dividend Yield

PE Ratio

-7.25

Earnings Per Share (EPS)

-1.72

Revenue

Net Profit

-63.78M

Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.celcuity.com

Headquarters

Wilmington, Delaware, USA

Founded

Celcuity Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CELC. The last closing price for Celcuity was $12. Over the last year, Celcuity shares have traded in a share price range of $ 11.51 to $ 22.188.

Celcuity currently has 37,129,556 shares outstanding. The market capitalization of Celcuity is $445.55 million. Celcuity has a price to earnings ratio (PE ratio) of -7.25.

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

Median overall survival (OS) among patients with HR+, HER2- advanced breast cancer who were treatment-naïve in the advanced setting was 77.3 months Median OS among patients previously treated...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1	-0.796178343949	12.56	13.02	11.64	374615	12.33015244	CS
4	-0.26	-2.04402515723	12.72	14.19	11.64	248096	12.71184599	CS
12	-1.95	-13.5322692575	14.41	16.5431	11.51	229745	13.96471056	CS
26	-2.4	-16.1507402423	14.86	19.77	11.51	318991	15.71896722	CS
52	-1.91	-13.2915796799	14.37	22.188	11.51	270769	16.03640961	CS
156	-0.11	-0.875099443119	12.57	22.188	4.81	134000	14.114984	CS
260	2.57	25.9858442872	9.89	33.01	4.03	112399	16.15967722	CS

CELC - Frequently Asked Questions (FAQ)

What is the current Celcuity share price?

The current share price of Celcuity is $ 12.46

How many Celcuity shares are in issue?

Celcuity has 37,129,556 shares in issue

What is the market cap of Celcuity?

The market capitalisation of Celcuity is USD 445.55M

What is the 1 year trading range for Celcuity share price?

Celcuity has traded in the range of $ 11.51 to $ 22.188 during the past year

What is the PE ratio of Celcuity?

The price to earnings ratio of Celcuity is -7.25

What is the reporting currency for Celcuity?

Celcuity reports financial results in USD

What is the latest annual profit for Celcuity?

The latest annual profit of Celcuity is USD -63.78M

What is the registered address of Celcuity?

The registered address for Celcuity is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Celcuity website address?

The website address for Celcuity is www.celcuity.com

Which industry sector does Celcuity operate in?

Celcuity operates in the MEDICAL LABORATORIES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	281.23M